The Library
Neo-tAnGo: a neoadjuvant randomized phase III trial of epirubicin/cyclophosphamide and paclitaxel +/- gemcitabine in the treatment of women with high-risk early breast cancer (EBC): first report of the primary endpoint, pathological complete response (pCR)
Tools
Tools
Tools
Earl, H. M., Vallier, A., Hiller, Louise, Fenwick, N., Iddawela, M., Hughes-Davies, L., Provenzano, E., McAdam, K., Hickish, T. and Caldas, C. (2009) Neo-tAnGo: a neoadjuvant randomized phase III trial of epirubicin/cyclophosphamide and paclitaxel +/- gemcitabine in the treatment of women with high-risk early breast cancer (EBC): first report of the primary endpoint, pathological complete response (pCR). In: 45th Annual Meeting of the American Society of Clinical Oncology, Orlando, FL, MAY 29-JUN 02, 2009. Published in: Journal of Clinical Oncology, Vol.27 (No.15 Suppl. S). Article: 522.
Full text not available from this repository.
Official URL: http://meeting.ascopubs.org/cgi/content/abstract/2...
| Item Type: | Conference Item (UNSPECIFIED) |
|---|---|
| Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
| Divisions: | Faculty of Medicine > Warwick Medical School |
| Journal or Publication Title: | Journal of Clinical Oncology |
| Publisher: | American Society of Clinical Oncology |
| ISSN: | 0732-183X |
| Date: | 20 May 2009 |
| Volume: | Vol.27 |
| Number: | No.15 Suppl. S |
| Number of Pages: | 2 |
| Page Range: | Article: 522 |
| Status: | Peer Reviewed |
| Publication Status: | Published |
| Access rights to Published version: | Restricted or Subscription Access |
| Description: | Meeting abstract |
| Title of Event: | 45th Annual Meeting of the American Society of Clinical Oncology |
| Type of Event: | Conference |
| Location of Event: | Orlando, FL |
| Date(s) of Event: | MAY 29-JUN 02, 2009 |
| URI: | http://wrap.warwick.ac.uk/id/eprint/5460 |
Data sourced from Thomson Reuters' Web of Knowledge
Actions (login required)
 |
View Item |
